Scarica l'app Stockscreener
25.28
0.23%
-0.0589
Dopo l'orario di chiusura:
25.31
0.0321
+0.13%
Precedente Chiudi:
$25.34
Aprire:
$25.18
Volume 24 ore:
1,386
Relative Volume:
0.98
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.25%
1M Prestazione:
+1.84%
6M Prestazione:
+5.67%
1 anno Prestazione:
+6.05%
Intervallo 1D:
$25.18
$25.31
Intervallo di 1 settimana:
$24.68
$25.40
Portata 52W:
$18.56
$26.27
Amplify Weight Loss Drug Treatment Etf Stock (THNR) Company Profile
Nome
Amplify Weight Loss Drug Treatment Etf
Settore
Industria
Telefono
-
Indirizzo
-
Confronta THNR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
THNR
Amplify Weight Loss Drug Treatment Etf
|
25.28 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.99 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
681.76 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
685.17 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
262.61 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
613.62 | 124.43B | 0 | 0 | 0 | 0.00 |
Amplify Weight Loss Drug Treatment Etf Borsa (THNR) Ultime notizie
Can You Buy Ozempic Stock in 2025? - The Motley Fool
2 Dividend ETFs to Avoid and 1 to Buy Right Now - AOL.com
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - PharmiWeb.com
ETFs Investing in JIANGSU HENGRUI PHARMACEUTICALS CO LTD Stocks - TradingView
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in - sharewise.com
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Benzinga
How (THNR) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Trading Systems Reacting to (THNR) Volatility - news.stocktradersdaily.com
3 Under-the-Radar Monthly Dividend ETFs - 24/7 Wall St.
SCHD Isn’t Your Only Option — 2 Monthly ETFs With Better Long-Term Gains - 24/7 Wall St.
The Investor's Guide to Buying GLP-1 Stocks - The Motley Fool
CF Acquisition Corp. VI (OTCMKTS:CFVIU) Trading Up 2.1% – Should You Buy? - Defense World
Elemental Altus Royalties (OTCMKTS:ELEMF) Trading Down 6.5% – Time to Sell? - Defense World
How Amplify Weight Loss Drug & Treatment Etf (THNR) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Defense Metals (CVE:DEFN) Trading Up 22.6% – Should You Buy? - Defense World
3 Monthly Dividend ETFs That Outperform SCHD and Pay You More Often - 24/7 Wall St.
Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs - Benzinga
2 Elite Dividend ETFs That Yield Over 5% - 24/7 Wall St.
Eli Lilly's LLY Surges 4.38% on Groundbreaking Obesity Drug Data – What's Next for the Pharma Giant? - AInvest
Discounted Ozempic Could Deflate ETF Optimism Around Hims & Hers - Benzinga
NVO Wins FDA Approval for MASH Treatment: ETFs Likely to Gain - Nasdaq
Novo Nordisk Surges 2.46% Amid Leadership Shift and Sector Volatility – What’s Fueling the Rally? - AInvest
Bank of America Issues Pessimistic Forecast for CAVA Group (NYSE:CAVA) Stock Price - Defense World
Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR) Short Interest Update - Defense World
Amgen Plummets 5.4% Amid MariTide Hype: Can This Biotech Giant Rebound? - AInvest
4 Super High-Yield Dividend Picks for Steady Passive Income - 24/7 Wall St.
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs - Yahoo Finance
3 Monthly-Paying Dividend ETFs Perfect for Retirement Income - 24/7 Wall St.
(THNR) On The My Stocks Page - news.stocktradersdaily.com
8 of the Safest High-Yielding ETFs That Will Protect Your Portfolio - 24/7 Wall St.
When (THNR) Moves Investors should Listen - news.stocktradersdaily.com
The 3 Best ETFs for Soaring Silver Prices - 24/7 Wall St.
(THNR) Proactive Strategies - news.stocktradersdaily.com
Weight-Loss Drug ETFs Generate Skinnier Returns Than Expected - Yahoo Finance
(THNR) Investment Analysis - news.stocktradersdaily.com
These 5 ETFs (QQQI, JEPQ, SCHD, DIVO, SPYI) Are Loved By Passive Income Seekers - 24/7 Wall St.
Weight Loss Drug ETF (THNR) Hits New 52-Week High - Yahoo
Investors Need To Buy This High-Yield, 11% ETF That Pays Cash Every Month - 24/7 Wall St.
ETF Spotlight: HIMZ on the Rise After Wegovy Hookup - ETF.com
The pharma war rocking global markets - ig.com
ETFs to Capitalize on the Novo Nordisk-Septerna Deal - Yahoo Finance
Amplify ETFs CEO Christian Magoon on the Past 2 Decades of ETFs - The Daily Upside
ETFs Tied to S&P 500 Top Performers Show Mixed Results - ETF.com
Why Weight-Loss Drugs Could Be Game-Changers for Your Investment Portfolio - Investopedia
Slower flows, small-cap woes, SEC nos! What to expect from ETFs in 2025 - Citywire
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs - ETF Trends
Amplify ETFs Achieves Landmark $10 Billion in Assets Under Management - GlobeNewswire
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - Yahoo Finance
Disruptive Theme of the Week: 2024's Top Investment Themes & Trends - ETF Trends
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
Best Crypto ETFs of November 2024 - AOL.com
Amplify Weight Loss Drug Treatment Etf Azioni (THNR) Dati Finanziari
Non sono disponibili dati finanziari per Amplify Weight Loss Drug Treatment Etf (THNR). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):